Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Health Information Technology and Healthcare Information System01:30

Health Information Technology and Healthcare Information System

3.6K
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.

Health technology assessment (Winchester, England)·2026
Same author

Rehabilitation intervention to improve Recovery after an Episode of Delirium in adults over 65 years (RecoverED): a multicentre, single-arm feasibility study in NHS acute hospitals in the UK.

BMJ open·2026
Same author

A rehabilitation intervention to improve recovery after delirium in older people: mixed methods process evaluation of the RecoverED multi-site feasibility study.

BMC geriatrics·2026
Same author

Measuring health-related quality of life in multiple sclerosis: comparing the acceptability, validity and responsiveness of the EQ-5D-3L and MSIS-8D.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2026
Same author

Developing a programme theory of a complex, home-based rehabilitation intervention for recovery after an episode of delirium.

PloS one·2026
Same author

Prehospital Whole Blood in Traumatic Hemorrhage - A Randomized Controlled Trial.

The New England journal of medicine·2026
Same journal

Are preference-weighted cancer-specific measures more sensitive than generic measures? A comparison of EQ-5D-5L, SF-6Dv2, FACT-8D and QLU-C10D in gastrointestinal cancers.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same journal

Development and Validation of a Brief Healthcare Insecurity Scale in a Sample of U.S. Adults Living with and without HIV.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same journal

A Competency Framework for Health Technology Assessment Expertise: Results from a Delphi Study.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same journal

Physician-led Switching from Reference Biologics to Biosimilars: What is the Effect on selected Health-Related Outcomes and Costs for IBD Patients in Germany?

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same journal

Critical Comments by the European Medicines Agency on Patient-Reported Outcomes in Regulatory Submissions (2020-2023).

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same journal

Interpreting the Economic Value of TPEx in Recurrent or Metastatic HNSCC: The Importance of Decision Context, Utility Timing, and Treatment Burden.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
See all related articles

Related Experiment Video

Updated: Mar 19, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.9K

Health Utilities for Multiple Sclerosis.

Annie Hawton1, Colin Green1

  • 1Health Economics Group, University of Exeter Medical School, University of Exeter, Exeter, UK.

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|June 22, 2016
PubMed
Summary
This summary is machine-generated.

Health state utility values (HSUVs) for multiple sclerosis (MS) decrease with disease severity and progression. Relapses significantly impact quality of life, underscoring the need for effective MS management strategies.

Keywords:
EQ-5DSF-6Dhealth state utilitymultiple sclerosis

More Related Videos

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

10.0K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.2K

Related Experiment Videos

Last Updated: Mar 19, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.9K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

10.0K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.2K

Area of Science:

  • Neurology
  • Health Economics
  • Quality of Life Research

Background:

  • Multiple sclerosis (MS) significantly impacts patients' health-related quality of life.
  • Estimating health state utility values (HSUVs) is crucial for cost-effectiveness analyses of MS treatments.
  • Existing data on HSUVs for MS populations, particularly using specific instruments like SF-6D, are limited.

Purpose of the Study:

  • To estimate HSUVs for individuals with MS based on demographic and clinical factors.
  • To provide detailed HSUVs using EQ-5D and SF-6D for different MS types and disease severities.
  • To assess the impact of relapses on HSUVs in the MS population.

Main Methods:

  • Analysis of data from a UK prospective, longitudinal cohort study of 1,441 people with MS.
  • Utilized patient-reported outcomes from the EuroQol five-dimensional questionnaire (EQ-5D) and the six-dimensional health state short form (SF-6D).
  • HSUVs were estimated by age, sex, MS type, time since diagnosis, disease severity (Expanded Disability Status Scale), and relapse characteristics.

Main Results:

  • Primary and secondary progressive MS were associated with lower HSUVs compared to relapsing-remitting MS.
  • HSUVs decreased significantly with increasing disease severity (EDSS scores 0-8).
  • Experiencing a relapse in the prior 6 months led to notable decrements in HSUVs (0.076 for EQ-5D, 0.052 for SF-6D).

Conclusions:

  • MS negatively affects health-related quality of life, particularly as the disease progresses.
  • Relapse characteristics substantially influence HSUVs, highlighting their importance in treatment evaluation.
  • These detailed HSUVs for the UK MS population offer valuable data for decision-makers assessing MS treatment effectiveness and cost-effectiveness.